DK3355889T3 - Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste - Google Patents

Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste Download PDF

Info

Publication number
DK3355889T3
DK3355889T3 DK16852340.5T DK16852340T DK3355889T3 DK 3355889 T3 DK3355889 T3 DK 3355889T3 DK 16852340 T DK16852340 T DK 16852340T DK 3355889 T3 DK3355889 T3 DK 3355889T3
Authority
DK
Denmark
Prior art keywords
diaminopyrimidine
cough
treatment
receptor modulators
modulators
Prior art date
Application number
DK16852340.5T
Other languages
English (en)
Inventor
Anthony P Ford
Kathleen Sereda Glaub
Michael M Kitt
Steven Smith
Original Assignee
Afferent Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afferent Pharmaceuticals Inc filed Critical Afferent Pharmaceuticals Inc
Application granted granted Critical
Publication of DK3355889T3 publication Critical patent/DK3355889T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK16852340.5T 2015-09-29 2016-09-23 Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste DK3355889T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562234584P 2015-09-29 2015-09-29
US201662336381P 2016-05-13 2016-05-13
PCT/US2016/053223 WO2017058645A1 (en) 2015-09-29 2016-09-23 Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of cough

Publications (1)

Publication Number Publication Date
DK3355889T3 true DK3355889T3 (da) 2023-05-15

Family

ID=58424436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16852340.5T DK3355889T3 (da) 2015-09-29 2016-09-23 Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste

Country Status (19)

Country Link
US (2) US11260056B2 (da)
EP (2) EP3355889B1 (da)
JP (1) JP6877441B2 (da)
KR (1) KR20180054843A (da)
AU (1) AU2016330466B2 (da)
CA (1) CA2998742C (da)
DK (1) DK3355889T3 (da)
ES (1) ES2942711T3 (da)
FI (2) FI3355889T3 (da)
HR (1) HRP20230445T1 (da)
HU (2) HUE061764T2 (da)
LT (1) LT3355889T (da)
MX (1) MX2018003893A (da)
NL (1) NL301260I2 (da)
PL (1) PL3355889T3 (da)
PT (1) PT3355889T (da)
RS (1) RS64155B1 (da)
SI (1) SI3355889T1 (da)
WO (1) WO2017058645A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102557242B1 (ko) 2016-12-20 2023-07-18 애퍼런트 파마슈티컬스 인크. P2x3 길항제의 결정질 염 및 다형체
US10111883B1 (en) * 2017-09-18 2018-10-30 Bellus Health Cough Inc. Selective P2X3 modulators
KR20210009341A (ko) * 2018-05-15 2021-01-26 바이엘 악티엔게젤샤프트 신경 섬유 감작과 연관된 질환의 치료를 위한 1,3-티아졸-2-일 치환된 벤즈아미드
ES2963702T3 (es) * 2018-10-05 2024-04-01 Shionogi & Co Medicina para tratar la tos crónica
WO2020221274A1 (zh) * 2019-04-30 2020-11-05 北京泰德制药股份有限公司 二氨基嘧啶类化合物治疗咳嗽的方法
WO2020239953A1 (en) 2019-05-31 2020-12-03 Chiesi Farmaceutici S.P.A. Pyridopyrimidines derivatives as p2x3 inhibitors
WO2020239952A1 (en) * 2019-05-31 2020-12-03 Chiesi Farmaceutici S.P.A. Amino quinazoline derivatives as p2x3 inhibitors
CN117843615A (zh) 2019-09-19 2024-04-09 盐野义制药株式会社 1,3,5-三嗪衍生物或其溶剂合物的晶体及其制造方法
CN111635368B (zh) * 2020-06-12 2021-06-29 东莞市东阳光仿制药研发有限公司 一种胺化合物的制备方法
WO2022112491A1 (en) 2020-11-27 2022-06-02 Chiesi Farmaceutici S.P.A. (aza)quinoline 4-amines derivatives as p2x3 inhibitors
EP4251620A1 (en) 2020-11-27 2023-10-04 Chiesi Farmaceutici S.p.A. Amino quinazoline derivatives as p2x3 inhibitors
CN116745284A (zh) 2020-11-27 2023-09-12 奇斯药制品公司 作为p2x3抑制剂的酞嗪衍生物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095359A1 (en) 2004-03-05 2005-10-13 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 antagonists
WO2006012639A2 (en) 2004-07-22 2006-02-02 Duska Scientific Co. Method of diagnosing, monitoring and treating pulmonary diseases
ATE529413T1 (de) 2005-09-01 2011-11-15 Hoffmann La Roche Verfahren zur synthese von aryloxydiaminopyrimidinen
WO2007025901A1 (en) 2005-09-01 2007-03-08 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
CN101296907B (zh) 2005-09-01 2013-03-27 弗·哈夫曼-拉罗切有限公司 作为p2x3和p2x2/3调节剂的二氨基嘧啶类
SI1924264T1 (sl) * 2005-09-01 2013-12-31 F. Hoffmann-La Roche Ag Diaminopirimidini kot modulatorji p2x3 in p2x2/3
DK2343281T3 (da) * 2006-10-04 2014-03-24 Hoffmann La Roche Fremgangsmåde til syntese af phenoxydiamino-pyrimidinderivater
WO2008104474A1 (en) * 2007-02-28 2008-09-04 F. Hoffmann-La Roche Ag Diaminopyrimidines
CR20160093A (es) 2013-08-23 2016-08-26 Afferent Pharmaceuticals Inc Moduladores del receptor p2x3 y p2x2/3 de diaminopiridina para el tratamiento de la tos aguda, sub aguda o cronica

Also Published As

Publication number Publication date
EP3355889A1 (en) 2018-08-08
US20220143015A1 (en) 2022-05-12
CA2998742C (en) 2023-08-29
RS64155B1 (sr) 2023-05-31
WO2017058645A1 (en) 2017-04-06
PT3355889T (pt) 2023-04-26
SI3355889T1 (sl) 2023-07-31
HUS2400004I1 (hu) 2024-04-28
HUE061764T2 (hu) 2023-08-28
JP6877441B2 (ja) 2021-05-26
LT3355889T (lt) 2023-05-10
CA2998742A1 (en) 2017-04-06
ES2942711T3 (es) 2023-06-06
FI3355889T3 (fi) 2023-05-15
JP2018529776A (ja) 2018-10-11
KR20180054843A (ko) 2018-05-24
EP4215182A1 (en) 2023-07-26
EP3355889A4 (en) 2019-05-22
MX2018003893A (es) 2018-06-22
FIC20240006I1 (fi) 2024-03-13
AU2016330466B2 (en) 2021-01-28
PL3355889T3 (pl) 2023-05-22
US20180280388A1 (en) 2018-10-04
US11260056B2 (en) 2022-03-01
EP3355889B1 (en) 2023-02-15
NL301260I2 (nl) 2024-03-25
AU2016330466A1 (en) 2018-03-29
HRP20230445T1 (hr) 2023-07-21

Similar Documents

Publication Publication Date Title
DK3355889T3 (da) Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste
HK1222126A1 (zh) 用於治療急性、亞急性或慢性咳嗽的二氨基嘧啶 受體調節劑
KR20180084817A (ko) 항-siglec-9 항체 및 이의 이용 방법
CL2016002364A1 (es) Indazol-3-carboxamidas 5-sustituidas y preparación y uso de las mismas
DK3207130T3 (da) Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme
JP2016540974A5 (ja) 光学撮像システム及びそれを用いた方法
MA43365A (fr) Anticorps anti-dr5 et procédés d'utilisation de ceux-ci
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
MA41296A (fr) Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
DK3882250T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser
DK3421993T3 (da) Diagnostisk fremgangsmåde og enhed til udførelse af det samme
DK3464292T3 (da) Modulatorer af beta-3-adrenerg receptor, der kan anvendes til behandling eller forebyggelse af lidelser relateret dertil
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3334693T3 (da) Kontinuerlig fremgangsmåde og system til behandlingen af spildevand
IL265648A (en) Compounds of p2x3 and/or p2x2/3 and methods for their preparation
DK3423060T3 (da) Imatinib til anvendelse til behandling af slagtilfælde
DK3719021T3 (da) Inhibitorer af adapterassocieret kinase 1, sammensætninger omfattende disse og fremgangsmåder til anvendelse deraf
DK3373922T3 (da) Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri
DK3291818T3 (da) Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler i colon
DK3239177T3 (da) Nyt egfrviii antistof og sammensætning omfattende samme
FR3018672B1 (fr) Dispositif de conditionnement et d'application.
DK3216335T3 (da) System og fremgangsmåde til registrering af vinden ved doseringsprocesser
DK3319621T3 (da) Sammensætninger og fremgangsmåder til modulering og/eller stimulering af immunrespons hos menneske og/eller dyr
DK3183568T3 (da) Indretning til fraktioneringen af objekter og fraktioneringsfremgangsmåde
DK3528951T3 (da) Doseringsindretning og fremgangsmåde til betjening af samme